[1]
Shahidi F. Nutraceuticals, functional foods and dietary supplements in health and disease. J Food Drug Anal 2012; 20(Suppl. 1): 226-30.
[2]
Shinde N, Bangar B, Deshmukh S, Kumbhar P. Nutraceuticals: A review on current status. Res J Pharm and Tech 2014; 7(1): 110-3.
[3]
DeFelice SL. The nutraceutical revolution: Its impact on food industry R&D. Trends Food Sci Technol 1995; 6(2): 59-61.
[13]
Hathcock J. Dietary supplements: How they are used andregulated. J Nutr 2001; 131(3s): 1114-7.
[14]
Prabhu SL, Suriya PTNK, Kumar CD, Suresh Kumar S, Ragavendran T. Nutraceuticals: A review. Elixir Pharm 2012; 46: 8372-7.
[15]
Rijk MC, Breteler MMB, Breeijen JH, et al. Dietary antioxidants and Parkinson’s disease, the Rotterdam study. Arch Neurol 1997; 54(6): 762-5.
[16]
Jialal I, Fuller CJ. Effect of vitamin E, vitamin C and beta carotene on the LDL oxidation and atherosclerosis. Can J Cardiol 1995; 11(Suppl. G): 97G-103G.
[17]
Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab 2000; 26(1): 22-7.
[18]
Wolman SL, Anderson GH, Marliss EB, Jeejeebhoy KN. Zinc in total parenteral nutrition: Requirements and metabolic effects. Gastroenterology 1979; 76(3): 458-67.
[19]
Black RE. Zinc deficiency, infectious disease and mortality in the developing world. J Nutr 2003; 133(5)(Suppl. 1): 1485S-9S.
[20]
Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997; 80(3): 331-3.
[21]
Dureja H, Kaushik D, Kumar V. Developments in nutraceuticals. Indian J Pharmacol 2003; 35: 363-72.
[22]
Wills RBH, Bone K, Morgan M. Herbal products: Active constituents, mode of action and quality control. Nutr Res Rev 2000; 13: 47-77.
[23]
Afzal M, Safer AM, Menon M. Green tea polyphenols and their potential role in health and disease. Inflammopharmacology 2015; 23(4): 151-61.
[24]
Braeckman J. The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study. Curr Ther Res 1994; 55(7): 776-85.
[25]
Abolhassani M. Antiviral activity of borage (Echium amoenum). Arch Med Sci 2010; 6(3): 366-9.
[26]
Lee G, Bae H. Therapeutic effects of phytochemicals and medicinal herbs on depression. BioMed Res Int 2017; 2017: 1-11.
[27]
Cavanagh HMA, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res 2002; 16(4): 301-8.
[28]
Gupta S, Chauhan D, Mehla K, Sood P, Nair N. An overview of nutraceuticals: Current scenario. Int J Basic Clin Pharmacol 2010; 1(2): 55-62.
[30]
Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomized trial. Lancet 2002; 359(9312): 1108-13.
[31]
Age-Related Eye Disease Study Research Group. A randomized, placebo controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119(10): 1417-36.
[32]
Age-Related Eye Disease Study Research Group. A randomized, placebo controlled clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001; 119(10): 1439-52.
[33]
Strause L, Saltman P, Smith KT, Bracker M, Andon MB. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994; 124: 1060-4.
[34]
Morelli L. Probiotics: Clinics and/or nutrition. Dig Liver Dis 2002; 34(Suppl. 2): 8-11.
[35]
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of noninsulin-dependent diabetes mellitus in women. JAMA 1997; 277(6): 472-7.
[36]
Slavin J, Jacobs D, Marquart L. Whole grain consumption and chronic disease: Protective mechanisms. Nutr Cancer 1997; 27(1): 14-21.
[37]
Pandey M, Verma RK, Saraf SA. Nutraceuticals: New era of medicine and health. Asian J Pharm Clin Res 2010; 3(1): 11-5.
[43]
Ministry of Health and Family Welfare. FSSAI. F.No.
2-15015/30/2010. Gazette notification. Prohibition
and restriction on sales (Part III, Section 4) 2011: 10-
6.
[44]
Ministry of Health and Family Welfare. FSSAI. F.No.
2-15015/30/2010. Gazette notification. Packaging and
labeling (Part III, Section 4) 2011: 29-53.
[45]
Ministry of Health and Family Welfare. FSSAI. F.No.
2-15015/30/2010. Gazette notification. Licensing and registration of food businesses started (Part III, Section
4) 2011: 65-118.
[46]
Ministry of Health and Family Welfare. FSSAI. F.No.
2-15015/30/2010. Gazette notification. Food product
standards and food additives (Part III, Section 4)
2011: 287-529.
[52]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification on referral laboratories (Part II, Section
3, sub-section ii) 2014.
[55]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification on Contaminants, Toxins and Residues
(amendment) (Part III Section 4) 2015.
[56]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification on Transaction of Business and Procedures
for the Scientific Committee and Scientific
Panels. (Part III, Section 4) December 2016.
[57]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification on import. (Part III, Section 4)
March 2017.
[58]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification (extraordinary) on Food recall procedure.
(Part III, Section 4) January 2017.
[59]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification (extraordinary) on organic food.
(Part III, Section 4) December 2017.
[60]
Ministry of Health and Family Welfare. FSSAI. Gazette
notification (extraordinary) on Alcoholic Beverages).
(Part III, Section 4) March 2018.